Table 1 Baseline characteristics in 40 patients

From: Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients

Age, years

68±24

Males, n (%)

31 (78)

Ischemic heart disease, n (%)

32 (80)

Cerebrovascular disease, n (%)

2 (5)

Diabetes, n (%)

18 (45)

Baseline ARBs

 Candesartan, n (%)

10 (25)

 Valsartan, n (%)

12 (30)

 Olmesartan, n (%)

6 (15)

 Telmisartan, n (%)

12 (30)

Combined drugs

 Ca blockers, n (%)

22 (55)

 β-Blockers, n (%)

5 (13)

 α-Blockers, n (%)

6 (15)

 Thiazide, n (%)

4 (10)

 Antidiabetic drugs, n (%)

14 (35)

 Statins, n (%)

35 (88)

  1. Abbreviation: ARB, angiotensin receptor blocker.
Back to article page